Cerebrospinal fluid levels of angiotensin- converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: A correlative study
- 1 December 1986
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 21 (14) , 1365-1381
- https://doi.org/10.1016/0006-3223(86)90328-8
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controlsLife Sciences, 1986
- Captopril and teprotide as discriminators of angiotensin-converting enzyme activity in brain tissueNeuroscience Letters, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A new feature of angiotensin-converting enzyme in the brain: Hydrolysis of substance PBiochemical and Biophysical Research Communications, 1983
- Reduced lumbar CSF somatostatin in levels in Alzheimer's diseaseLife Sciences, 1982
- Peptides in the cerebrospinal fluid of neuropsychiatric patients: An approach to central nervous system peptide functionLife Sciences, 1982
- The Identity of the Serotonin‐Sensitive Aryl Acylamidase with Acetylcholinesterase from Human Erythrocytes, Sheep Basal Ganglia and Electric EelEuropean Journal of Biochemistry, 1980
- Angiotensin converting enzyme in the Parkinsonian brainAnnals of Neurology, 1978
- Acetylcholinesterase-catalyzed hydrolysis of an amideBiochemistry, 1975
- 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndromeLife Sciences, 1967